Improving cancer prevention trial processes
Official title: Improving the Processes around Approval, Accrual and Translational Research in Cancer Prevention Trials
Funded at University of Kansas Medical Center · NIH-10782131 · Data updated 2026-11-12
This study is all about finding better ways to help people join clinical trials that focus on preventing cancer before it starts, and it will involve testing new cancer vaccines and markers to improve health outcomes for patients at the University of Kansas Cancer Center.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $172,197 |
| NIH project number | 1R50CA285494-01 |
| Project ID | NIH-10782131 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals at high risk for gastrointestinal cancers, particularly those with familial predispositions.
✕Less likely to help
Patients with advanced cancer or those not at risk for gastrointestinal malignancies may not benefit from this research.
What this research studies
This research focuses on enhancing the processes that support clinical trials aimed at intercepting cancer, particularly at the University of Kansas Cancer Center. It aims to establish efficient methods for patient accrual and trial approval, emphasizing active strategies to prevent cancer before it develops. The project will involve collaboration with various cancer prevention and control programs, leveraging existing research and clinical expertise to improve outcomes. Patients may be involved in trials that test innovative cancer vaccines and biomarkers.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer prevention strategies and improved patient outcomes.
How similar studies have gone: Previous research in cancer interception has shown promise, indicating that proactive approaches can significantly impact cancer prevention.
Where this research is happening
-
University of Kansas Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Bansal, Ajay — University of Kansas Medical Center
- Study coordinator: Bansal, Ajay
Related research
Other NIH-funded projects on the same topics.
-
Motor-Cognitive Training for Older Adults at Risk of Dementia
A Phase II trial tests a combined motor and cognitive training program for older adults at risk of dementia to see if it helps daily function and slows dementia onset.
-
MOVE Peds: Moving Toward Better Outcomes for Pediatric FSHD
A study in kids with a rare muscle disease (FSHD) will test how well certain outcomes reflect change and help guide future clinical trials.
-
How DNA methylation changes in our cells affect gene activity
This project studies how chemical changes to DNA, and the way DNA is packaged, influence how genes turn on or off in vertebrate cells.
-
Dietary oxysterols and metabolic dysfunction in the gut-liver axis
Aims to understand how oxidized cholesterol byproducts in processed foods affect gut and liver health, especially in adults with type 2 diabetes or related conditions.
-
Intermittent fasting and blood sugar in adults with diabetes
A study will look at how two forms of intermittent fasting might improve blood sugar control in adults with type 2 diabetes.
-
Dysfunctional fat tissue and its link to fatty liver and diabetes
Researchers are studying how problems in fat tissue contribute to fatty liver disease and type 2 diabetes in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.